Bio Planet (FRA:8WS) YoY EBITDA Growth: 1.19% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8WS Bio Planet SA FRA:8WS
78 GF Score
Price €6.28
GF Value €4.93
! 2 Warning Signs
View Full Analysis

What is Bio Planet YoY EBITDA Growth?

Bio Planet FRA:8WS -0.32% 78 YoY EBITDA Growth is 1.19% as of Mar. 2026. GuruFocus rates FRA:8WS with a GF Score™ of 78/100 and a GF Value™ of €4.93. The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bio Planet's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 1.19%.

Bio Planet's EBITDA per Share for the three months ended in Mar. 2026 was €0.34.

Bio Planet YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Bio Planet's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Planet YoY EBITDA Growth Chart

Bio Planet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.45 -43.93 60.33 19.02 68.38

Bio Planet Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.90 100.00 50.00 81.33 1.19
FRA:8WS
78GF Score
Bio Planet SA FRA:8WS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Planet YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bio Planet's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.98-0.582)/ | 0.582 |
=68.38 %

Bio Planet's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.339-0.335)/ | 0.335 |
=1.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 1.19% mean?
Bio Planet (FRA:8WS) has a YoY EBITDA Growth of 1.19% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Bio Planet and its competitors.
Is Bio Planet's YoY EBITDA Growth too high?
Bio Planet's current YoY EBITDA Growth is 1.19%. Overall, Bio Planet has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Bio Planet's YoY EBITDA Growth compare to KHC and GIS?
Bio Planet's YoY EBITDA Growth of 1.19% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Consumer Packaged Goods company?
A good YoY EBITDA Growth depends on the Consumer Packaged Goods industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Bio Planet and its competitors. Bio Planet's current YoY EBITDA Growth is 1.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Planet stock overvalued right now?
Bio Planet (FRA:8WS) has a current YoY EBITDA Growth of 1.19%. The stock's GF Value™ is €4.93, compared to a current price of €6.28 — trading 27.4% above its estimated fair value. The current YoY EBITDA Growth is 1.19%. Bio Planet's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Bio Planet (FRA:8WS), the current YoY EBITDA Growth is 1.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Planet (FRA:8WS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Planet stock appears to be overvalued. The current stock price of €6.28 is trading 27.4% above its estimated GF Value™ of €4.93.

Key valuation signals for FRA:8WS:

  • YoY EBITDA Growth: 1.19%
  • GF Value™: €4.93 vs. price of €6.28 (27.4% above fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the FRA:8WS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Planet Business Description

Other Exchanges BIP:Poland
Address Wilkowa Wies 7, Leszno k, Warsaw, POL, 05-084
Bio Planet SA is a producer and distributor of organic food under its own brand Bio Planet. It also develops the department of organic foodservice packaging (private label). The product offerings of the company include Marmalades, Proteins, Sauces, Legumes, Vegetables, Sausages and Spices and Herbs among others.
78GF Score

Get the complete analysis for FRA:8WS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.28
Price
€4.93
GF Value